Treatment of Hyperhidrosis With Oxybutynin (NCT01855256) | Clinical Trial Compass
CompletedPhase 3
Treatment of Hyperhidrosis With Oxybutynin
France62 participantsStarted 2013-06
Plain-language summary
Evaluation of the effectiveness of oxybutynin in hyperhidrosis
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age greater than 18 years
* Patient affiliated to social security or beneficiary of such a regime
* Patient able to consent
* Patient with hyperhidrosis, generalized or localized (palmar, plantar, axillary) and whose score HDSS (Hyperidrosis Disease Severity Scale) is greater than two.
Exclusion Criteria:
* Age less than 18 years
* Patient who can't be followed
* Patient participating in another clinical trial
* Pregnant
* Woman breastfeeding
* Hypersensitivity to oxybutynin or any of the excipients
* Risk of urinary retention related disorders uretroprostatiques
* Intestinal obstruction
* Toxic megacolon
* Intestinal atony
* Severe Ulcerative Colitis
* Myasthenia
* Closure glaucoma the anterior chamber angle or slightly deep
What they're measuring
1
Evaluation of the effectiveness of oxybutynin in hyperhidrosis